Physician

Jacob N Jorns, MD

According to 2025 Medicare claims, Jacob Jorns, MD (NPI: 1871737064) practices urology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF MOBILE, P.A. (NPI: 1194828368; TIN: 63-0576885) and primary practice location at 36532-3160.

Jorns' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 859 traditional Medicare patients, billed 16,388 HCPCS/CPT codes, and received $310,560 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,473 prescription claims across 462 beneficiaries totaling $150,027 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 17 claims. Open Payments data shows 41 records totaling $1,016. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $71,798 to $310,560. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $42,213 to $150,027. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $226 and ending at $283.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$155K$311K2015 Medicare payment: $71,798 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $109,237 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $107,221 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $135,564 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $123,078 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $118,785 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $134,347 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $151,444 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $198,728 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $310,560 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154561,103$71,798
20166181,492$109,237
20176571,607$107,221
20187611,914$135,564
20198481,807$123,078
20208342,303$118,785
20218281,737$134,347
20228741,850$151,444
20237257,426$198,728
202485916,388$310,560

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$231K2015 Drug cost: $42,213 (USD; Tot_Drug_Cst)2016 Drug cost: $71,406 (USD; Tot_Drug_Cst)2017 Drug cost: $88,218 (USD; Tot_Drug_Cst)2018 Drug cost: $109,056 (USD; Tot_Drug_Cst)2019 Drug cost: $165,824 (USD; Tot_Drug_Cst)2020 Drug cost: $197,429 (USD; Tot_Drug_Cst)2021 Drug cost: $189,563 (USD; Tot_Drug_Cst)2022 Drug cost: $192,086 (USD; Tot_Drug_Cst)2023 Drug cost: $231,107 (USD; Tot_Drug_Cst)2024 Drug cost: $150,027 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015189714$42,213
20162731,210$71,406
20173451,472$88,218
20183981,637$109,056
20194251,682$165,824
20204582,041$197,429
20214702,015$189,563
20225422,008$192,086
20235951,987$231,107
20244621,473$150,027

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$32K2015 Medicare payment: $4,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,125 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $6,840 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $13,498 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,780 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $31,016 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $32,110 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $30,814 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $13,742 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $4,478 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R38$4,248
2016N/R79$11,125
2017N/R42$6,840
2018N/R62$13,498
20191264$9,780
202014116$31,016
202115105$32,110
202215105$30,814
2023N/R72$13,742
2024N/R17$4,478

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more414738$130
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more437614$88
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's567982$13
51798Ultrasound measurement of bladder capacity after voiding278357$7
81003Automated urinalysis test6411,148$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron963,240$48,612
GemtesaVibegron702,808$44,964
OrgovyxRelugolix11330$28,718
NitrofurantoinNitrofurantoin Macrocrystal1485,025$6,908
Tamsulosin HclTamsulosin Hcl51828,346$5,666

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R17$4,478

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$1,016ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jacob N. Jorns, MD?

Tedicare shows public-source Medicare data for Jacob N. Jorns, MD (NPI 1871737064), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacob N. Jorns, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jacob N. Jorns, MD?

Jacob N. Jorns, MD is linked to UROLOGY ASSOCIATES OF MOBILE, P.A. (billing NPI 1194828368) in the available physician profile data.

Does Jacob N. Jorns, MD have Open Payments data?

Jacob N. Jorns, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.